Higher Post-absorptive C-peptide Levels in Type 1 Diabetic Patients Without Renal Complications
Overview
Affiliations
Geiger M, Janes T, Keshavarz H, Summers S, Pinger C, Fletcher D Sci Rep. 2020; 10(1):17493.
PMID: 33060722 PMC: 7566639. DOI: 10.1038/s41598-020-74527-6.
Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.
Ghorbani A, Shafiee-Nick R World J Diabetes. 2015; 6(1):145-50.
PMID: 25685285 PMC: 4317306. DOI: 10.4239/wjd.v6.i1.145.
Physiological effects and therapeutic potential of proinsulin C-peptide.
Yosten G, Maric-Bilkan C, Luppi P, Wahren J Am J Physiol Endocrinol Metab. 2014; 307(11):E955-68.
PMID: 25249503 PMC: 4254984. DOI: 10.1152/ajpendo.00130.2014.
Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds.
Almeida M, Dantas J, Barone B, Serfaty F, Kupfer R, Albernaz M Clinics (Sao Paulo). 2013; 68(1):123-6.
PMID: 23420171 PMC: 3552451. DOI: 10.6061/clinics/2013(01)rc02.
Cifarelli V, Geng X, Styche A, Lakomy R, Trucco M, Luppi P Diabetologia. 2011; 54(10):2702-12.
PMID: 21773684 DOI: 10.1007/s00125-011-2251-0.